STOCK-BASED COMPENSATION	9 Months Ended
Dec. 31, 2018
Share-based Compensation [Abstract]
STOCK-BASED COMPENSATION	During the three months ended December 31, 2018, we granted options for a total of 28,661 shares with a weighted average grant date fair value of $0.87 per option. During the nine months ended December 31, 2018, we granted options for a total of 1,264,687 shares with a weighted average grant date fair value of $0.55 per option. The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the three months ended December 31, 2018: (i) dividend yield on our common stock of 0 percent, (ii) expected stock price volatility of 88 percent, (iii) a risk-free interest rate of 3.2 percent for options granted from July to October, and 2.52 percent for options granted in November and December, and (iv) and expected option term of 8 years for 1,200,000 shares of option granted, and 5 years for 64,687 shares of option granted. General and administrative expense for the three and nine months ended December 31, 2018 included stock-based compensation expense of $12,500 and $20,833. Research and development expenses also include stock-based compensation expenses of $178,670 and $353,173 for the three and nine months ended December 31, 2018. As of December 31, 2018, the unrecognized stock-based compensation expenses related to non-vested stock options was approximately $330,000, which will be amortized over an estimated weighted average period of approximately 6 months.

STOCK-BASED COMPENSATION

9 Months Ended

Dec. 31, 2018

During the three months ended December 31, 2018, we granted options for a total of 28,661 shares with a weighted average grant date fair value of $0.87 per option. During the nine months ended December 31, 2018, we granted options for a total of 1,264,687 shares with a weighted average grant date fair value of $0.55 per option.

The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the three months ended December 31, 2018: (i) dividend yield on our common stock of 0 percent, (ii) expected stock price volatility of 88 percent, (iii) a risk-free interest rate of 3.2 percent for options granted from July to October, and 2.52 percent for options granted in November and December, and (iv) and expected option term of 8 years for 1,200,000 shares of option granted, and 5 years for 64,687 shares of option granted.

General and administrative expense for the three and nine months ended December 31, 2018 included stock-based compensation expense of $12,500 and $20,833. Research and development expenses also include stock-based compensation expenses of $178,670 and $353,173 for the three and nine months ended December 31, 2018.

As of December 31, 2018, the unrecognized stock-based compensation expenses related to non-vested stock options was approximately $330,000, which will be amortized over an estimated weighted average period of approximately 6 months.